Home › Funds › Dauntless Investment Group, LLC › EPRX
Dauntless Investment Group, LLC position in EPRX
EUPRAXIA PHARMACEUTICALS INC · Health Care
Dauntless Investment Group, LLC reported holding 71,341 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$649K, representing 0.66% of its reported portfolio and ranking #23 among its reported holdings. Dauntless Investment Group, LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Dauntless Investment Group, LLC's EPRX position evolved
Dauntless Investment Group, LLC first disclosed a stake in EPRX in Q3 2026 at 71,341 shares (US$649K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 71.34K | $649.20K | New |
About EPRX and 13F data
EPRX (EUPRAXIA PHARMACEUTICALS INC) is a Health Care company. 72 other funds we track also report a position in EPRX — the largest reported positions include Bellevue Group AG (US$23.6M), Affinity Asset Advisors, LLC (US$15.6M), Vivo Capital, LLC (US$12.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EPRX
- Bellevue Group AG 2.60M sh · $23.62M · Q3 2026
- Affinity Asset Advisors, LLC 1.72M sh · $15.62M · Q3 2026
- Vivo Capital, LLC 1.35M sh · $12.29M · Q3 2026
- GREAT POINT PARTNERS LLC 1.20M sh · $10.92M · Q3 2026
- Caligan Partners LP 1.16M sh · $10.58M · Q3 2026
- PFM Health Sciences, LP 1.13M sh · $10.26M · Q3 2026
- Ikarian Capital, LLC 809.74K sh · $7.37M · Q3 2026
- Seven Fleet Capital Management LP 572.27K sh · $5.21M · Q3 2026
- Redmile Group, LLC 519.88K sh · $4.73M · Q3 2026
- DAFNA Capital Management LLC 404.57K sh · $3.68M · Q3 2026
- Velan Capital Investment Management LP 352.00K sh · $3.20M · Q3 2026
- Aisling Capital Management LP 325.00K sh · $2.96M · Q3 2026
More on Dauntless Investment Group, LLC
FAQ
How long has Dauntless Investment Group, LLC held EPRX?
Dauntless Investment Group, LLC has disclosed EPRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Dauntless Investment Group, LLC's current position in EPRX?
As of Q3 2026, Dauntless Investment Group, LLC holds 71.34K shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), valued at $649.20K, representing 0.66% of its reported portfolio and ranking #23.
Has Dauntless Investment Group, LLC been buying or selling EPRX?
In the latest 13F filing (Q3 2026), Dauntless Investment Group, LLC newly opened its position in EPRX.
Which other funds hold EPRX?
Other major institutional holders of EPRX include Bellevue Group AG, Affinity Asset Advisors, LLC, Vivo Capital, LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.